Consistent with the results described above, the expression of PRPF19 dramatically increased in tumor tissues compared with that in paired adjacent non-tumor tissues (Fig. 1D, E), and was higher in tumor tissues of stage III-IV patients than that in stage I-II patients (Fig. 1F). This evidence concerns the gene PRPF19 and neoplasm.